https://www.youtube.com/watch?v=3LWNY70Oj4A
Carl Hart is a psychologist at Columbia University. Here he talks about heroin, cocaine, MDMA, alcohol & the role of drugs in society.
Read morePSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
https://www.youtube.com/watch?v=3LWNY70Oj4A
Carl Hart is a psychologist at Columbia University. Here he talks about heroin, cocaine, MDMA, alcohol & the role of drugs in society.
Read moreKeep reading for an interview with pioneering psychedelic activist Rick Doblin about the promise of MDMA therapy for PTSD, working with Republicans, and his hope for a drug-assisted global spiritual awakening.
Read moreThe disguises we wear every day… Hiding your feelings can be freeing. But eventually you have to take off the mask.
Read moreHere’s an enthralling review of Kingsley’s Catafalque.
Read moreRethinking the role of the default mode network in psychedelics: dissolving ego dissolution.
Read morePodcast on psychedelics: the science, research, and medical implications with Dr. Fred Barrett.
Dr. Frederick Barrett is a cognitive neuroscientist with training in behavioral pharmacology. He has been conducting psychedelic research at Johns Hopkins University since 2013. He has explored the effects of psilocybin on the brain, the effects of LSD on the brain’s response to music, and is currently leading a number of ongoing studies aimed at better understanding the psychological, biological, and neural mechanisms underlying the therapeutic efficacy of psychedelic drugs.
Read moreCan psychedelics help the dying? How science is reviving this ancient connection with death and psychedelics.
Read moreAmy Emerson is the Chief Executive Officer at the MAPS Public Benefit Corporation (MAPS PBC), a fully owned subsidiary of the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS).
Working for almost two decades to make MDMA a legal, FDA-approved medicine, Amy began as a pro bono consultant for MAPS in 2003, helping to create MAPS’ clinical department and managing the MDMA Clinical Development Program.
Her painstaking time and efforts have played a key role in seeing MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) through clinical trials, driving it ever-closer to being a legal, accessible therapeutic treatment in the US and abroad.
Read more"I hope in the big picture, by 2050, we'll have enough people with an understanding of how to use psychedelics for personal, emotional, and spiritual growth that we'll have a more spiritualized humanity to turn us more towards saving the planet from mass weapons, climate change, and prejudice," explains Doblin.
Read moreCould psychedelics ease mental health toll from COVID-19, and other crises?
Read more